BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11056496)

  • 1. Pathology of benign prostatic hyperplasia.
    Foster CS
    Prostate Suppl; 2000; 9():4-14. PubMed ID: 11056496
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a new in vitro model for the study of benign prostatic hyperplasia.
    Habib FK; Ross M; Bayne CW
    Prostate Suppl; 2000; 9():15-20. PubMed ID: 11056497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
    Matsuda T; Fujime M; Suda K
    Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign prostatic hyperplasia: a stromal disease].
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Höpfl R; Rohr HP
    Urologe A; 1989 Nov; 28(6):321-8. PubMed ID: 2481358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
    J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cells of the human prostate: initial isolation and characterization.
    Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
    Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue microenvironment and benign prostatic hyperplasia.
    Wei X; Xin L
    Aging (Albany NY); 2019 Jun; 11(11):3414-3415. PubMed ID: 31195369
    [No Abstract]   [Full Text] [Related]  

  • 8. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.
    Barclay WW; Woodruff RD; Hall MC; Cramer SD
    Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia and prostate cancer.
    Guess HA
    Epidemiol Rev; 2001; 23(1):152-8. PubMed ID: 11588841
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathophysiology of benign prostatic hyperplasia.
    Djavan B; Remzi M; Erne B; Marberger M
    Drugs Today (Barc); 2002 Dec; 38(12):867-76. PubMed ID: 12582474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate development and growth in benign prostatic hyperplasia.
    Timms BG; Hofkamp LE
    Differentiation; 2011; 82(4-5):173-83. PubMed ID: 21939815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
    Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
    Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic stromal hyperplasia with bizarre nuclei.
    Chang J; Pathak AS; Dikranian AH; Danial T; Patel HS; Kaswick JA
    J Urol; 2003 Nov; 170(5):1951. PubMed ID: 14532823
    [No Abstract]   [Full Text] [Related]  

  • 14. 4. Steroid pathophysiology of BPH. Correlative morphological and biochemical investigations on the stromal tissue of the human prostate.
    Bartsch G; Daxenbichler G; Rohr HP
    J Steroid Biochem; 1983 Jul; 19(1A):147-54. PubMed ID: 6193337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.
    Xu H; Fu S; Chen Y; Chen Q; Gu M; Liu C; Qiao Z; Zhou J; Wang Z
    Clin Sci (Lond); 2017 Apr; 131(7):595-607. PubMed ID: 28130436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile of primary prostate epithelial and stromal cells in response to sulforaphane or iberin exposure.
    Chambers KF; Bacon JR; Kemsley EK; Mills RD; Ball RY; Mithen RF; Traka MH
    Prostate; 2009 Sep; 69(13):1411-21. PubMed ID: 19489030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C; Luo F; Zhou Y; Du X; Shi J; Zhao X; Xu Y; Zhu Y; Hong W; Zhang J
    Exp Cell Res; 2016 Jul; 345(2):125-33. PubMed ID: 25849092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness and significance of prostatic ischemia in rabbit].
    Shen W; Zhang W; Bi Y; Deng ZX; Lü J; Qiu XF; Li P; Wang BQ; Zhang CL; Hu WL
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3224-7. PubMed ID: 20193539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia: morphometric studies in relation to the hormone sensitivity of stromal tissue.
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Höpfl R; Rohr HP
    Prog Clin Biol Res; 1994; 386():51-65. PubMed ID: 7528421
    [No Abstract]   [Full Text] [Related]  

  • 20. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
    Li W; Wu CL; Febbo PG; Olumi AF
    Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.